StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
Ampio Pharmaceuticals stock opened at $0.29 on Friday. The stock’s 50 day moving average is $1.28 and its 200 day moving average is $1.92. The firm has a market cap of $326,040.00, a P/E ratio of -0.03 and a beta of 1.95. Ampio Pharmaceuticals has a one year low of $0.14 and a one year high of $8.30.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last posted its quarterly earnings data on Wednesday, March 27th. The company reported ($2.48) EPS for the quarter.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- Why is the Ex-Dividend Date Significant to Investors?
- High-Yield Texas Instruments Could Hit New Highs Soon
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Use the MarketBeat Dividend Calculator
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
